Harvard University's Office of Technology Development and Oxford
Nanopore Technologies Ltd today announced an agreement to progress nanopore
science by integrating Harvard discoveries with technology in development at
Under the terms of this agreement with Harvard, Oxford Nanopore has exclusive
rights to develop and commercialize a number of nanopore technological breakthroughs
developed in the laboratories of three investigators at Harvard and their collaborators
at the University of California Santa Cruz (UCSC) and the National Institute
of Standards and Technology (NIST), an agency of the US Department of Commerce.
The investigators include: Professors Daniel Branton, George Church and Jene
Golovchenko at Harvard; David Deamer and Mark Akeson at UCSC and John Kasianowicz
These academics have pioneered the research of DNA translocation through nanopores
and the potential for DNA sequencing using this method. This is complementary
to the work of Professor Hagan Bayley, the founder of Oxford Nanopore Technologies.
Professor Bayley pioneered the field of nanopores as sensors of single molecules,
with a specific focus on the identification of DNA bases.
Oxford Nanopore will also support fundamental nanopore research at Harvard,
facilitating further advancement of the field and generating opportunities for
further evolutions of nanopore sequencing technology.
"The inventions licensed to Oxford Nanopore resulted from strong collaboration
across multiple disciplines at Harvard, and also with academic colleagues from
outside of the University," said Isaac T. Kohlberg, Senior Associate Provost
and Chief Technology Development Officer at Harvard University. "This work
and the agreement announced today are further validation of Harvard's strong
commitment to collaboration and innovation, and to ensuring that the work of
our scientists is extended to benefit society more broadly."
Dr Gordon Sanghera, CEO of Oxford Nanopore Technologies, added: "We are
proud to collaborate with this world-class research team. Harvard's long record
of excellence in nanopore research means that this agreement encompasses many
aspects of nanopore technology. Through this partnership and agreements with
other prestigious institutions, Oxford Nanopore takes the leading position in
transforming nanopores from science into technologies that will benefit researchers
and people everywhere."
Oxford Nanopore is developing nanopores for use in DNA sequencing and the analysis
of other molecules. A nanopore is a small hole; this inner diameter is small
enough to be used in the direct identification of many single molecules, without
using chemical labels. This technology has the potential to deliver a dramatic
reduction in the cost and speed of DNA sequencing, benefiting basic medical
research and further the field of personalized medicine.
A dramatic improvement in sequencing technology would have a profound effect
on life science and medical research, furthering genome research and the development
of new medical diagnostics, treatments and strategies. There are many additional
applications of sequencing, within the fields of defense, energy and agriculture.
The single molecule analysis platform being developed at Oxford Nanopore is
label-free, and is therefore positioned to deliver a step-change in the power
and cost of DNA sequencing. While current technologies rely on expensive fluorescent
labels, optical equipment for signal detection and informatics to translate
image data into sequence data, nanopores bypass the optical detection by providing
a direct electrical recording of DNA base identification. The method is highly
scalable through silicon chip arrays.
Financial terms of the agreement were not disclosed.
The Harvard Nanopore Group is led by Professor Daniel Branton and Professor
Jene Golovchenko. The group has been investigating electronic methods of very
rapidly detecting, characterizing and sequencing single molecules of DNA. A
detector consisting of a single nanopore in a thin, insulating, solid-state
membrane could mimic the function of a-hemolysin pores in lipid bilayers, while
serving as a platform for integrated electronic detection devices. The group's
research has lead to the development of a new ion beam based method for creating
nanoscale structures in semiconductors called "ion beam sculpting".
The Group is also developing other applications that may utilize the sensitivity
and speed of nanopore probing, and is investigating the physics of DNA polymer
movement through the confined space of a nanopore, coordinating the application
of material science tools to fabricate solid-state nanopores, and developing
the associated biochemistry, molecular biology, electronics, and signal processing
to effect molecular recognition. http://www.mcb.harvard.edu/branton/
Oxford Nanopore is developing nanopore technology, a revolutionary method of
molecular detection and analysis with potential for DNA sequencing, diagnostics,
drug development and defence applications. The company was founded on the science
of Professor Hagan Bayley of the University of Oxford, who pioneered the stochastic
sensing of single molecules using engineered protein nanopores, and has published
a method to differentiate between DNA bases using a nanopore.
The Company's BASE technology is a system for DNA sequencing that employs nanopores
to process, identify and record DNA bases in sequence. In contrast to current
sequencing technologies, nanopores offer a potential method of directly sequencing
DNA at single molecule resolution. This removes the need for amplification or
labelling, and allows detection from an electrical signal rather than by fluorescence-based
CCD imaging. In order to make a breakthrough in speed and cost, other competing
technologies require step changes in optics, computation and CCD camera technologies.
Nanopores provide an alternative path to a step-change in the power and cost
of DNA sequencing.
Recent interest in the "race for the $1000 genome" illustrates the
needs for a sequencing technology that is affordable and powerful enough to
provide more researchers with affordable sequencing power. This is expected
to enable an exponential increase in research and understanding of the genome,
and accelerate new developments in medicine, agriculture, energy, biodiversity,
evolutionary biology, genealogy and many other fields.
The nanopore molecular detection system is powerful and versatile beyond its
DNA sequencing potential. It can be adapted to detect a wide range of molecules,
including other nucleic acids, proteins, small organic molecules and ionic species.
Oxford Nanopore Technologies holds license agreements for the development and
commercialization of nanopore technology with the foremost institutions in nanopore
science. These include the University of Oxford, Harvard University, the University
of California, Santa Cruz, Texas A&M, the University of Massachusetts Medical
School and the National Institute of Standards and Technology (NIST). This places
the Company in a unique and leading position for bringing first and future generations
of nanopore technology to the market.